TriSalus Life Sciences share price logo

TriSalus Life Sciences

NASDAQ: TLSI

$3.57

-0.09

(-2.46%)

Live

as on

TriSalus Life Sciences Stock Performance

as on October 24, 2026 at 6:27 am IST

  • Day's High

    $3.57
    $3.70

    3.64%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.20
    $7.95
    downward going graph

    38.38%

    Downside

    122.69%

    Upside

    downward going graph

TriSalus Life Sciences share price movements today

Previous Close
$3.66
Open
$3.70
Volume
134.1K
Market Cap
$226.0M
Day's Low - High
$3.57 - $3.70
52 Week Low - High
$2.20 - $7.95

TriSalus Life Sciences Historical Returns

1 Month Return
-26.8 %
3 Month Return
-14.29 %
1 Year Return
-28.65 %
3 Year Return
-27.74 %
5 Year Return
0 %

TriSalus Life Sciences Stock Fundamentals & Key Indicators

Check TriSalus Life Sciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$226.0M

EPS (TTM)

-1.3

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.82

Industry PE ratio

-5.10

PEG Ratio

0.05

EBITDA

-21.7M

Revenue (TTM)

45.1M

Profit Margin

85.79%

Return On Equity TTM

273.71%

TriSalus Life Sciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of TriSalus Life Sciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
TriSalus Life Sciences image
TriSalus Life Sciences
StrongBuy$226.0MNA-2.8285.79%0.00%
Medtronic image
Medtronic
Buy$121.0B-21.53%22.7566.69%3.07%
Edwards Lifesciences image
Edwards Lifesciences
Buy$51.0B-22.73%50.8077.98%0.00%
Stryker image
Stryker
StrongBuy$116.8B11.37%30.5965.17%1.18%
Abbott Laboratories image
Abbott Laboratories
StrongBuy$173.9B-19.11%32.3456.80%2.51%
See all

Stock Returns calculator for TriSalus Life Sciences Stock including INR - Dollar returns

The TriSalus Life Sciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

TriSalus Life Sciences investment value today

Current value as on today

₹75,268

Returns

-₹24,732

(-24.73%)

Returns from TriSalus Life Sciences Stock

-₹30,409 (-30.41%)

Dollar Impact

₹5,677 (+5.68%)

Analyst Recommendation on TriSalus Life Sciences Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for TriSalus Life Sciences. Average target price of $10.4

TriSalus Life Sciences Share Price Target

Get share price movements and forecasts by analysts on TriSalus Life Sciences.

What analysts predicted

65.67%UPSIDE

Target Price

$10.4

Current Price

$3.57

Analyzed by

3 Analysts

High

$12

Target

$10.40

Low

$7

TriSalus Life Sciences target price $10.4, a slight upside of 65.67% compared to current price of $3.57. According to 3 analysts rating.

Indian Investors' Interest in TriSalus Life Sciences Stock

Search interest for TriSalus Life Sciences Stock has increased by 492% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:492% versus previous 30 day period

TriSalus Life Sciences Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
6
7
7
8
9
11
11
13
8
11
Gross Profit
5
6
6
7
7
9
9
11
7
9
Operating Income
-11
-8
-8
-7
-7
-7
-9
-3
-8
-9
EBITDA
-13
-3
-1
-8
-8
-6
-9
-8
3
-7
Interest Expense
0
0
1
1
1
1
1
1
1
1
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-13
-4
-2
-10
-10
-8
-10
-9
1
-9
Income Tax Expense
0
0
0
0
0
0
0
-
0
0
Net Income
-13
-4
-2
-10
-10
-8
-10
-9
1
-9
Net Profit Margin
84.96%
87.62%
86.34%
85.28%
83.69%
83.93%
83.52%
86.66%
86.18%
86.78%

TriSalus Life Sciences Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Mar 2024
Dec 2024
Dec 2025
Total Revenue
-
8
12
18
29
45
Gross Profit
-
7
10
15
25
38
Operating Income
0
-24
-36
-54
-36
-26
EBITDA
0
-26
-46
-58
-32
-33
Interest Expense
-
1
0
0
3
5
Depreciation
-
0
0
0
0
0
Income Before Tax
0
-28
-47
-59
-30
-39
Income Tax Expense
-
0
0
0
0
0
Net Income
-31
-28
-47
-59
-33
-39
Net Profit Margin
0.00%
85.80%
81.79%
85.93%
86.06%
84.57%

TriSalus Life Sciences Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-13
-4
-2
-10
-10
-8
-10
-9
1
-7
Operating Cash Flow
-10
-13
-10
-5
-4
-7
-3
-2
-6
-16
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
3
25
5
2
9
20
0
0
42
42
Change in Cash
-7
12
-5
-2
4
13
-3
-2
36
25

TriSalus Life Sciences Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Mar 2024
Dec 2024
Dec 2025
Net Income
0
-28
-47
-59
-30
-39
Operating Cash Flow
0
-22
-32
-50
-40
-18
Investing Cash Flow
-250
-2
-1
-1
0
0
Financing Cash Flow
252
50
13
54
37
30
Change in Cash
1
25
-20
2
-3
11

Global Institutional Holdings in TriSalus Life Sciences

Check out the Institutions with significant holdings in TriSalus Life Sciences.

Funds
Holdings
Vanguard
3.23%
iShares
2.67%
WASATCH FUNDS TRUST
2.31%
VANGUARD INDEX FUNDS
2.09%
Travis Knapp Anderson
1.38%
See all

TriSalus Life Sciences News & Key Events

  • img

    Today's Timeline - 22 September

    Wed, 01:50 AM

    -

    TriSalus Life Sciences receives FDA clearance for TriNav Advance, enhancing its Pressure-Enabled Drug Delivery portfolio for embolization procedures.

Insights on TriSalus Life Sciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 8.89M → 11.40M (in $), with an average increase of 22.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Medtronic plc has given 30.5% return, outperforming this stock by 58.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 17.7% return, outperforming this stock by 46.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, TLSI stock has moved down by -26.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 1.53M → -9.18M (in $), with an average decrease of 697.0% per quarter

About TriSalus Life Sciences

TriSalus Life Sciences, Inc. is an immunotherapy firm dedicated to the research, development, and market introduction of treatments that leverage the body's immune system, primarily targeting liver and pancreatic cancers. The company's product portfolio includes the TriNav Infusion System, designed for hepatic arterial infusion to treat liver tumors, and the Pancreatic Retrograde Venous Infusion System, which addresses pancreatic tumors. Additionally, TriSalus is advancing SD-101, an investigational immunotherapeutic that incorporates pressure-enabled drug delivery technology. This experimental therapy is currently being explored for its application in hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company's operations are headquartered in Westminster, Colorado.
OrganisationTriSalus Life Sciences
Headquarters6272 West 91st Avenue, Westminster, CO, 80031, US
IndustryMedical - Devices
CEOMary T. Szela

Key Management of TriSalus Life Sciences

Name

Title

Mr. David B. Patience

Chief Financial Officer

Dr. Richard B. Marshak M.B.A., VMD

Chief Commercial Officer

Andrea Marasso

Vice President of Marketing

Ms. Jennifer L. Stevens J.D.

Chief Regulatory, Quality and Therapeutics Officer

Dr. Bryan F. Cox Ph.D.

Chief of Research

Dr. Richard Marshall M.D.

Chief Medical Officer

FAQs

What is TriSalus Life Sciences share price today?

TriSalus Life Sciences share price today is $3.57 as on . TriSalus Life Sciences share today touched a day high of $3.70 and a low of $3.57.

What is the 52 week high and 52 week low for TriSalus Life Sciences share?

TriSalus Life Sciences share touched a 52 week high of $7.95 on and a 52 week low of $2.20 on . TriSalus Life Sciences stock price today i.e. is trending at $3.57,which is 55.09% down from its 52 week high and 62.27% up from its 52 week low.

What is TriSalus Life Sciences's market capitalisation today?

TriSalus Life Sciences market capitalisation is $0.00T as on .

How to invest in TriSalus Life Sciences Stock (TLSI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for TriSalus Life Sciences on INDmoney app. Click on Buy button.

What is the minimum amount required to buy TriSalus Life Sciences Stock (TLSI) from India?

Indian investors can start investing in TriSalus Life Sciences (TLSI) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in TriSalus Life Sciences stock (as per the Rupee-Dollar exchange rate as on ). Based on TriSalus Life Sciences share’s latest price of $3.57 as on October 24, 2026 at 12:57 am IST, you will get 2.8011 shares of TriSalus Life Sciences. Learn more about fractional shares .